Spectrum Pharmaceuticals Operating Income

Spectrum Pharmaceuticals (SPPI) currently reports a operating income of $-64M as of March 2023. That compares with $-130M in the prior-year period — up 50.4% year over year. Use the charts on this page to explore Spectrum Pharmaceuticals's operating income history and peer comparisons.

Spectrum Pharmaceuticals's operating income increased from $-130M to $-64M — a 50.4% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Spectrum Pharmaceuticals reported $-64M in operating income as of March 2023. That compares with $-130M in the prior-year period — up 50.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Spectrum Pharmaceuticals, and consider following SPPI for alerts when major investors trade the stock.

Spectrum Pharmaceuticals is classified in the Healthcare sector. On operating income, it currently shows $-64M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPPI with unrelated industries.